A 66-year-old woman was diagnosed with primary antiphospholipid syndrome (APS) after suffering four embolic strokes with large vessel occlusion over two years, according to a case report published in Brain Circulation. The patient’s condition was initially misattributed to atrial fibrillation and unsuccessfully treated with direct oral anticoagulants before a switch to Vitamin K antagonists stopped the recurrences.
Antiphospholipid syndrome is a known but rare cause of embolic ischemic stroke. While it is associated with up to 20% of strokes in individuals under 50, it is considered a very seldom cause of stroke
in patients over 50, according to a case report published June 26, 2024, in the journal Brain Circulation.
Four strokes and mechanical thrombectomies in a 66-year-old patient
The patient, a 66-year-old white woman, experienced four embolic strokes involving large vessel occlusion within a two-year window. According to the report by Anatoli Anastasiadi et al., each of these events was treated with mechanical thrombectomy, which the authors describe as successful. Despite these interventions, the patient continued to suffer stroke recurrences.
Medical teams initially attributed the strokes to atrial fibrillation. Based on this diagnosis, the patient was treated with direct oral anticoagulants. However, this treatment regimen failed to prevent further embolic events, leading clinicians to investigate other etiologies for the recurrent strokes.
Diagnosis of primary APS via anti-beta 2-glycoprotein antibodies
The diagnosis of primary antiphospholipid syndrome was eventually reached after the patient presented with isolated anti-beta 2-glycoprotein antibodies. This finding shifted the treatment strategy away from the previously prescribed direct oral anticoagulants.
Following the initiation of Vitamin K antagonist therapy, the patient experienced no further strokes. The report identifies this specific case as an example of late-onset APS, which can present a significant diagnostic challenge in elderly patients where the syndrome is less commonly suspected.
Diagnostic imaging and clinical findings at Klinikum Stuttgart
The case was managed across multiple specialties at Klinikum Stuttgart, including the departments of Neurology, Nephrology, Cardiology, and Neuroradiology, with additional involvement from the Neurologische Klinik at the Medizinische Fakultät Mannheim, Universität Heidelberg.
- CT perfusion.
The authors conclude that for elderly patients experiencing recurrent embolic strokes despite the use of oral anticoagulation, late-onset APS should be considered as a rare but possible etiology.
Related reading
- Women’s Health Strategy: No Improvement After One Year as Minister Lacks Urgency
- How the Corona Pandemic Fueled the Fintech Boom: The Rise of Payment Giants like Adyen
- Antiphospholipid Syndrome Management Shifts Toward Individualized Care (archyworldys.com)
- Antiphospholipid Syndrome Case Highlights Stroke Risks in Elderly Patients (time.news)